COMMUNIQUÉS West-GlobeNewswire

Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue
07/08/2018
Total revenue of $99.5 million, a 31% increase over 2017 Net product sales of $97.0 million, a 32% increase over 2017 Operating earnings of $35.7 million, a 37% increase over 2017 Diluted earnings per share (GAAP) of $0 [...]
Calithera Biosciences Reports Second Quarter 2018 Financial Results and Recent Highlights
07/08/2018
- Two Novel Programs Entering Clinical Development -Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Calithera [...]
Alder BioPharmaceuticals® Reports Second Quarter 2018 Financial and Operating Results
07/08/2018
- Presented new eptinezumab Phase 3 clinical trial data in episodic and chronic migraine demonstrating robust efficacy that is sustained and further improved after repeat quarterly treatments - - Biologics License [...]
Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights
07/08/2018
Clinical data updates and regulatory feedback for VY-AADC during the quarter support planned pivotal program for Parkinson’s disease Pipeline programs progressing with updated preclinical data from ALS and Huntington’s [...]
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
07/08/2018
Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular [...]
Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
07/08/2018
Net loss was $59.9 million in the second quarter and $108.6 million for the first six months ended June 30, 2018 Net cash from operating and investing activities was $58.0 million in the second quarter and $26.3 million [...]
GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
SOUTH SAN FRANCISCO, Calif. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York City [...]
Athersys Reports Second Quarter 2018 Results
07/08/2018
Management to host conference call at 4:30pm EDT today CLEVELAND, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2018. [...]
miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
07/08/2018
Cobomarsen expansion indication data released; first observations from the ongoing Phase 1 clinical trial on safety and efficacy of cobomarsen in ATLL patients, additional data expected by year end New cobomarsen Phase [...]
MRI Interventions, Inc. to Announce Second Quarter 2018 Results on August 14
07/08/2018
IRVINE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 second quarter, which ended June 30, 2018, on Tuesday, August 14, 2018 [...]
Inovio Pharmaceuticals Reports 2018 Second Quarter Financial Results
07/08/2018
PLYMOUTH MEETING, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted [...]
Sunesis Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights
07/08/2018
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2018 Financial Results
07/08/2018
MINNEAPOLIS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
07/08/2018
Pipeline expanded with gene therapy technologies including AXO-Lenti-PD for treatment of Parkinson’s Disease and AXO-AAV-OPMD for treatment of oculopharyngeal muscular dystrophy Ilise Lombardo, MD, promoted to Chief [...]
Zafgen Reports Second Quarter 2018 Operating and Financial Results
07/08/2018
Phase 1 clinical trial for ZGN-1258 for Prader-Willi syndrome (PWS) expected to begin in the fourth quarter 2018 Multiple ZGN-1258 nonclinical studies accepted for presentation at upcoming Foundation for Prader-Willi [...]
VIVUS Reports Second Quarter 2018 Financial Results
07/08/2018
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and [...]
Bellicum Pharmaceuticals Reports Second Quarter 2018 Financial Results
07/08/2018
Management to host conference call and webcast today at 5 p.m. Eastern HOUSTON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular [...]
Cutera Reports Second Quarter 2018 Financial Results
07/08/2018
Second Quarter Revenue of $42.6 Million, an Increase of 17% Year-over-Year Rest of World System Revenue Grew 26% in the Second Quarter BRISBANE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“ [...]

Pages